Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I study of OPB-51602, an oral inhibitor of signal transducer and activator of transcription 3, in patients with relapsed/refractory hematological malignancies.
Ogura M, Uchida T, Terui Y, Hayakawa F, Kobayashi Y, Taniwaki M, Takamatsu Y, Naoe T, Tobinai K, Munakata W, Yamauchi T, Kageyama A, Yuasa M, Motoyama M, Tsunoda T, Hatake K. Ogura M, et al. Among authors: motoyama m. Cancer Sci. 2015 Jul;106(7):896-901. doi: 10.1111/cas.12683. Epub 2015 May 25. Cancer Sci. 2015. PMID: 25912076 Free PMC article. Clinical Trial.
Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignancies.
Wong AL, Soo RA, Tan DS, Lee SC, Lim JS, Marban PC, Kong LR, Lee YJ, Wang LZ, Thuya WL, Soong R, Yee MQ, Chin TM, Cordero MT, Asuncion BR, Pang B, Pervaiz S, Hirpara JL, Sinha A, Xu WW, Yuasa M, Tsunoda T, Motoyama M, Yamauchi T, Goh BC. Wong AL, et al. Among authors: motoyama m. Ann Oncol. 2015 May;26(5):998-1005. doi: 10.1093/annonc/mdv026. Epub 2015 Jan 21. Ann Oncol. 2015. PMID: 25609248 Free article. Clinical Trial.
Expression of matrix metalloproteinase 2 (MMP-2), membrane-type 1 MMP and tissue inhibitor of metalloproteinase 2 and activation of proMMP-2 in pancreatic duct adenocarcinomas in hamsters treated with N-nitrosobis(2-oxopropyl)amine.
Iki K, Tsutsumi M, Kido A, Sakitani H, Takahama M, Yoshimoto M, Motoyama M, Tatsumi K, Tsunoda T, Konishi Y. Iki K, et al. Among authors: motoyama m. Carcinogenesis. 1999 Jul;20(7):1323-9. doi: 10.1093/carcin/20.7.1323. Carcinogenesis. 1999. PMID: 10383907
Effects of the plasma concentration of 5-fluorouracil and the duration of continuous venous infusion of 5-fluorouracil with an inhibitor of 5-fluorouracil degradation on Yoshida sarcomas in rats.
Fujii S, Shimamoto Y, Ohshimo H, Imaoka T, Motoyama M, Fukushima M, Shirasaka T. Fujii S, et al. Among authors: motoyama m. Jpn J Cancer Res. 1989 Feb;80(2):167-72. doi: 10.1111/j.1349-7006.1989.tb02285.x. Jpn J Cancer Res. 1989. PMID: 2498251 Free PMC article.
Inhibition of spontaneous rat osteosarcoma lung metastasis by 3S-[4-(N-hydroxyamino)-2R-isobutylsuccinyl]amino-1-methoxy-3,4-dihydroc arbostyril, a novel matrix metalloproteinase inhibitor.
Kido A, Tsutsumi M, Iki K, Motoyama M, Takahama M, Tsujiuchi T, Morishita T, Tatsumi K, Tamai S, Konishi Y. Kido A, et al. Among authors: motoyama m. Jpn J Cancer Res. 1999 Mar;90(3):333-41. doi: 10.1111/j.1349-7006.1999.tb00752.x. Jpn J Cancer Res. 1999. PMID: 10359049 Free PMC article.
Manganese electrode for all-solid-state fluoride batteries.
Inoishi A, Setoguchi N, Motoyama M, Okada S, Sakaebe H. Inoishi A, et al. Among authors: motoyama m. Chem Commun (Camb). 2025 Jan 2. doi: 10.1039/d4cc04418e. Online ahead of print. Chem Commun (Camb). 2025. PMID: 39744937
159 results